Vee Excel Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.82 M
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 22.79 Cr
- Satisfied Charges ₹ 21.10 Cr
- Revenue Growth -7.33%
- Profit Growth -86.67%
- Ebitda -32.09%
- Net Worth 1.24%
- Total Assets -5.28%
About Vee Excel Drugs And Pharmaceuticals
Vee Excel Drugs And Pharmaceuticals Private Limited (VEDAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 March 2000 and has a history of 24 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.82 M.
The company currently has active open charges totaling ₹22.79 Cr. The company has closed loans amounting to ₹21.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipin Bansal and Anu Bansal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239DL2000PTC104382
-
Company No.
104382
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2000
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Vee Excel Drugs And Pharmaceuticals Private Limited offer?
Vee Excel Drugs And Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs, Cosmetics, Hair & Beauty Products, Skin Creams, Ayurvedic & Herbal Health Supplement.
Who are the key members and board of directors at Vee Excel Drugs And Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Bansal
|
Whole-Time Director | 14-Feb-2004 | Current |
|
Anu Bansal
|
Director | 01-Sep-2001 | Current |
Financial Performance of Vee Excel Drugs And Pharmaceuticals.
Vee Excel Drugs And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.33% decrease. The company also saw a substantial fall in profitability, with a 86.67% decrease in profit. The company's net worth moved up by a moderate rise of 1.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vee Excel Drugs And Pharmaceuticals?
In 2023, Vee Excel Drugs And Pharmaceuticals had a promoter holding of 84.08% and a public holding of 15.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vxl Natural Health And Hygiene Private LimitedVipin Bansal and Anu Bansal are mutual person
-
Vrx World Pharmacy Private Limited
Vipin Bansal and Anu Bansal are mutual person
Charges (Loans)
₹227.91 M
₹210.99 M
Charges Breakdown by Lending Institutions
- Others : 22.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2024 | Others | ₹4.56 Cr | Open |
| 30 Mar 2019 | Others | ₹18.23 Cr | Open |
| 16 Sep 2021 | Sidbi | ₹1.50 Cr | Satisfied |
| 02 Jun 2021 | Sidbi | ₹1.56 Cr | Satisfied |
| 14 Oct 2016 | Sidbi | ₹4.00 Cr | Satisfied |
How Many Employees Work at Vee Excel Drugs And Pharmaceuticals?
Vee Excel Drugs And Pharmaceuticals has a workforce of 11 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vee Excel Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vee Excel Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.